Search Results 711-720 of 16328 for monoclonal antibody

  1. A Trial of ZL-1201 in Subjects with Advanced Cancer - Mayo Clinic

    ... Antibody ZL-1201 in Subjects with Advanced Cancer. Participation eligibility ... Previous exposure to any anti-CD-47 monoclonal antibody or SIRPα antibody.

  2. Fractionated Anti HLA Antibodies Role in Prevention of Sold Organ Transplant Rejection - Mayo Clinic

    About this study. The purpose of this study is to develop single chain variable fragment antibodies against HLA A2 and test their efficacy in blocking the ...

  3. Mayo Clinic Podcast - Dr. Gregory Poland - YouTube Audio Exp...

    antibody levels. So when exposed, they could develop disease ... Some of the mutations are making vaccines, plasma, monoclonal antibodies less effective.

  4. A Study of Using Lorvotuzumab Mertansine in Treating Younger Patients with Relapsed or Refractory Wilms Tumor, Rhabdomyosarcoma, Neuroblastoma, Pleuropulmonary Blastoma, Malignant Peripheral Nerve Sheath Tumor, or Synovial Sarcoma - Mayo Clinic

    Antibody-drug conjugates, such as lorvotuzumab mertansine, are created by ... monoclonal antibody; ≥ 2 weeks must have elapsed since local palliative ...

  5. Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis

    Study identifies clinical phenotype, visual outcomes of MOG-IgG antibody optic neuritis ... Two novel glial autoantibodies discovered in the past 15 years enable ...

  6. Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma (SEQUEL) - Mayo Clinic

    ... monoclonal antibody or hypersensitivity to pembrolizumab or any of its excipients. * Has had a prior anti-cancer monoclonal antibody (mAb), excluding anti ...

  7. A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-cell Maturation Antigen (BCMA) in Participants With Multiple Myeloma - Mayo Clinic

    ... monoclonal antibody and. B-cell maturation antigen (BCMA)-directed therapy - Cohort D: Newly diagnosed multiple myeloma per IMWG with a history of 4 to 8 ...

  8. A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation - Mayo Clinic

    A Study of the Safety and Effectiveness of Eculizumab to Prevent Antibody-Mediated Rejection in ABO Blood Group Incompatible Living Donor Kidney Transplantation.

  9. Tebentafusp Regimen Versus Investigator's Choice in Previously Treated Advanced Melanoma (TEBE-AM) - Mayo Clinic

    * previous severe hypersensitivity reaction to treatment with another monoclonal antibody (mAb) * active autoimmune disease requiring immunosuppressive ...

  10. A Study of the Effectiveness and Safety of Mepolizumab as Adjunctive Therapy in Participants with Severe Eosinophilic Asthma - Mayo Clinic

    Participants who have received any monoclonal antibody (other than Xolair) to treat inflammatory disease within 5 half-lives of visit 1; Participants who ...